ThomasEdwardLadMD

Oncology • Chicago, IL

Chairman, Hematology/Oncology Division Cook County Health and Hospitals System

Join to view full profile

Dr. Lad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lad's full profile

Already have an account?

Office
1950 W Polk St
Chicago, IL 60612
Phone+1 312-864-7260

Fax+1 312-864-9002
Is this information wrong?

Education & Training

University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1976 - 1978
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1971 - 1976
Ohio State University College of MedicineClass of 1971

Certifications & Licensure

IL State Medical License 1972 - 2026
IL State Medical License 1971 - 2026
OH State Medical License 1971 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
Active, not recruiting
Phase 3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
Completed
Phase 2
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer Start of enrollment: 2012 Dec 06
Completed
Phase 2
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
Recruiting
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Correction to: Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health‑related quality of life and supportive care needs.
Maras, A., Penedo, F., Ramirez, A., Worch, S., Ortiz, M., Yanez, B., Munoz, E., Medina, H., Moreno, P., Lad, T., Hollowell, C.> ;Supportive Care in Cancer. 2023 Dec 6
Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health-related quality of life and supportive care needs.
Ashley F Maras, Frank J Penedo, Amelie G Ramirez, Sarah M Worch, Manuel S Ortiz, Betina Yanez, Edgar Munoz, Thomas Lad, Courtney Hollowell, Heidy N Medina, Patricia I ...> ;Supportive Care in Cancer. 2023 Nov 20
23 citations
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international,...
Linda R Mileshkin, Kathleen N Moore, Elizabeth H Barnes, Val Gebski, Kailash Narayan, Madeleine T King, Nathan Bradshaw, Yeh Chen Lee, Katrina Diamante, Anthony W Fyle...> ;The Lancet. Oncology. 2023 May 1
2 citations
Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Ran...
Christopher L Hallemeier, Jennifer Moughan, Michael G Haddock, Arnold M Herskovic, Bruce D Minsky, Mohan Suntharalingam, Kenneth L Zeitzer, Madhur K Garg, Bruce D Gree...> ;JAMA Network Open. 2023 Apr 3
3 citations
Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples.
Christina Nowicki, Lucille Ray, Philip Engen, Andrea Madrigrano, Thomas Witt, Thomas Lad, Melody Cobleigh, Ece A Mutlu> ;Frontiers in Microbiology. 2023 Jan 1
A latent class analysis of health behavior changes after cancer diagnosis among Hispanic/Latino cancer survivors.
Blanca S Noriega Esquives, Sara M St George, Patricia I Moreno, Tae Kyoung Lee, Edgar Munoz, Thomas Lad, Alan Pollack, Courtney M P Hollowell, Amelie G Ramirez, Frank ...> ;Journal of Cancer Survivorship. 2022 Dec 2
7 citations
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
Alexander H.G. Paterson, Peter C. Lucas, Stewart J. Anderson, Eleftherios P. Mamounas, Adam Brufsky, Luis Baez-Diaz, Karen M. King, Thomas E. Lad, André Robidoux, Mela...> ;JNCI Cancer Spectrum. 2021 May 28
1 citations
A Low Literacy, Multimedia Health Information Technology Intervention to Enhance Patient-Centered Cancer Care in Safety Net Settings Increased Cancer Knowledge in a Ra...
John Devin Peipert, Thomas E. Lad, Pam Khosla, Sofia F. Garcia, Elizabeth A. Hahn> ;Cancer Control. 2021 Jan 1
2 citations
Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients.
Surabhi Pathak, Romy Jose Thekkekara, Udit Yadav, Ahmed T Ahmed, Barbara Yim, Thomas E. Lad, Michael Russell Mullane, Kumar Kunnal Batra, Wilbert S. Aronow, Sarah P. P...> ;American Journal of Therapeutics. 2021 Jul 1
4 citations
Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)
Manish R. Sharma, Shailly Mehrotra, Elizabeth Gray, Kehua Wu, William T. Barry, Clifford A. Hudis, Eric P. Winer, Alan P. Lyss, Deborah Toppmeyer, Alvaro Moreno-Aspiti...> ;Journal of Clinical Pharmacology. 2020 Apr 1
1 citations
Gastric Cancer in a Patient with Laparoscopic Adjustable Gastric Band: Case Report and Review of Literature.
Ankit Mangla, Pei Lu, Michael Russell Mullane, Thomas E. Lad> ;Journal of Gastrointestinal Cancer. 2019 Sep 1
42 citations
Unmet supportive care needs in Hispanic/Latino cancer survivors: prevalence and associations with patient-provider communication, satisfaction with cancer care, and sy...
Patricia I. Moreno, Amelie G. Ramirez, Sandra L. San Miguel-Majors, Leopoldo Castillo, Rina S. Fox, Kipling J. Gallion, Edgar Munoz, Ryne Estabrook, Arely Perez, Thoma...> ;Supportive Care in Cancer. 2019 Apr 1
5 citations
Carfilzomib-associated cardiovascular adverse events in a non-Caucasian cohort of patients with multiple myeloma: A real-world experience.
Ankit Mangla, Koosha Paydary, Jiaxiang Liu, Chimezie Mbachi, Barbara Yim, Thomas E. Lad> ;Hematological Oncology. 2018 Aug 3
46 citations
Satisfaction with Cancer Care, Self-Efficacy, and Health-Related Quality of Life in Latino Cancer Survivors
Patricia I. Moreno, Amelie G. Ramirez, Sandra L. San Miguel-Majors, Rina S. Fox, Leopoldo Castillo, Kipling J. Gallion, Edgar Munoz, Ryne Estabrook, Arely Perez, Thoma...> ;Cancer. 2018 Apr 15
6 citations
Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabe...
Shailly Mehrotra, Manish R. Sharma, Elizabeth Gray, Kehua Wu, William T. Barry, Clifford A. Hudis, Eric P. Winer, Alan P. Lyss, Deborah Toppmeyer, Alvaro Moreno-Aspiti...> ;The AAPS Journal. 2017 Jun 15
1 citations
Erlotinib Induced Fatal Interstitial Lung Disease in a Patient with Metastatic Non-Small Cell Lung Cancer: Case Report and Review of Literature.
Ankit Mangla, Nikki Agarwal, Chou Carmel, Thomas E. Lad> ;Rare Tumors. 2016 Oct 5
247 citations
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Sarah Burdett, Jean Pierre Pignon, Jayne F. Tierney, Hélène Tribodet, Lesley A. Stewart, Cécile Le Péchoux, Anne Auperin, Thierry Le Chevalier, Richard Stephens, Rodri...> ;The Cochrane Database of Systematic Reviews. 2015 Mar 2
27 citations
Age-Related Cataract in Men in the Selenium and Vitamin E Cancer Prevention Trial Eye Endpoints Study: A Randomized Clinical Trial
William G. Christen, Robert J. Glynn, J. Michael Gaziano, Amy K. Darke, John Crowley, Phyllis J. Goodman, Scott M. Lippman, Thomas E. Lad, James D. Bearden, Gary E. Go...> ;JAMA Ophthalmology. 2015 Jan 1
59 citations
A Randomized Trial of Weekly Symptom Telemonitoring in Advanced Lung Cancer
Susan Yount, Nan E. Rothrock, Michael Bass, Jennifer L. Beaumont, Deborah Pach, Thomas E. Lad, Jyoti D. Patel, Maria E. Corona, Rebecca Weiland, Katherine Del Ciello, ...> ;Journal of Pain and Symptom Management. 2014 Jun 1
16 citations
Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy.
Tareq Braik, Barbara Yim, Arthur T. Evans, Mohammed A. Kassem, Michael Russell Mullane, Thomas E. Lad, Lily Hussein, Barbara Cleveland, Susan McDunn> ;The Journal of Community and Supportive Oncology. 2014 Feb 1
11 citations
Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the conte...
Susan Magasi, Rajiv Mallick, Karen Kaiser, Jyoti D. Patel, Thomas E. Lad, Melissa Lynne Johnson, Edward H. Kaplan, David Cella> ;Clinical Lung Cancer. 2013 May 1
6 citations
Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorption.
Edith C. Abramson, Jeffry Chang, Marjorie Mayer, Lawrence J. Kukla, Daniel H. Shevrin, Thomas E. Lad, Robert Buschman, Subhash C. Kukreja> ;Journal of Bone and Mineral Research. 2009 Dec 3
7 citations
Effect of epidermal growth factor infusion on serum and urine calcium in mice.
Daniel H. Shevrin, Thomas E. Lad, Subhash C. Kukreja> ;Journal of Bone and Mineral Research. 2009 Dec 3
306 citations
Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative
Sofia F. Garcia, David Cella, Steven B. Clauser, Kathryn E. Flynn, Thomas E. Lad, Jin Shei Lai, Bryce B. Reeve, Ashley Wilder Smith, Arthur A. Stone, Kevin P. Weinfurt> ;Journal of Clinical Oncology. 2007 Nov 10
12 citations
Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.
Thomas E. Lad, Fred Rosen, D. Sciortino, Bruce Brockstein, Keubler Jp, R. Arietta, Everett E. Vokes> ;Investigational New Drugs. 2000 Aug 1
Join now to see all

Grant Support

Stroger Hospital Cook County MU NCORPNCI2020–2026

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

John H. Stroger Jr. Hospital of Cook CountyChicago, Illinois
University of Illinois HospitalChicago, Illinois
Jesse Brown VA Medical CenterChicago, Illinois